ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG – Trademark Portfolio
Entity Type: 03
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ICHTHYOL. The owner is based in HAMBURG.
SPORTALLEE 85
HAMBURG D-22335 , DE
Showing of trademarks Trademarks
Trademark Classifications
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG have?
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG file in?
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG's most well-known trademarks?
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG's registered trademark portfolio includes well-known marks such as ICHTHYOL. These are among 1 currently registered trademark in the portfolio.
What is ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG's trademark registration success rate?
ICHTHYOL-GESELLSCHAFT CORDES, HERMANNI & CO. (GMBH & CO.) KG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.